Raymond W. Cohen is the Chief Executive Officer of Axonics, Inc., a medical technology company focused on improving lives with innovative therapies. He has led Axonics since its inception in 2013 and has extensive experience in the medical device industry....

Raymond W. Cohen is the Chief Executive Officer of Axonics, Inc., a medical technology company focused on improving lives with innovative therapies. He has led Axonics since its inception in 2013 and has extensive experience in the medical device industry. Cohen has served on the boards of various publicly traded life sciences companies, which gives him a broad view of the sector. In 2023, he received a total compensation package of $1.65 million, showing strong alignment with performance goals set by the board of directors. His recent agreement extends his tenure to 2025 and includes significant bonuses tied to company performance, highlighting his commitment to achieving results. Also, Cohen owns about 694,930 shares in Axonics, indicating that he has skin in the game when it comes to the company's success. His past experience includes leadership roles in other renowned medical companies, including Cardiac Science and Vessix Vascular, which enriches his understanding of the landscape and enhances Axonics’ strategy as it navigates challenges and opportunities ahead.